Compare · APDN vs SE
APDN vs SE
Side-by-side comparison of Applied DNA Sciences Inc. (APDN) and Sea Limited (SE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APDN and SE operate in Other Consumer Services (Consumer Discretionary), so they compete in similar markets.
- SE is the larger of the two at $56.40B, about 2354.5x APDN ($24.0M).
- Over the past year, APDN is up 2.5% and SE is down 45.9% - APDN leads by 48.5 points.
- SE has hit the wire 2 times in the past 4 weeks while APDN has been quiet.
- SE has more recent analyst coverage (25 ratings vs 2 for APDN).
- Company
- Applied DNA Sciences Inc.
- Sea Limited
- Price
- $5.67+31.25%
- $92.13+3.02%
- Market cap
- $24.0M
- $56.40B
- 1M return
- +142.31%
- +9.06%
- 1Y return
- +2.53%
- -45.93%
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2017
- News (4w)
- 0
- 2
- Recent ratings
- 2
- 25
Applied DNA Sciences Inc.
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Sea Limited
Sea Limited, together with its subsidiaries, engages in the digital entertainment, e-commerce, and digital financial service businesses in Southeast Asia, Latin America, rest of Asia, and internationally. It provides Garena digital entertainment platform for users to access mobile and PC online games, as well as eSports operations; and access to other entertainment content, such as livestreaming of gameplay and social features, such as user chat and online forums. The company also operates Shopee e-commerce platform, a mobile-centric marketplace that offers integrated payment and logistics infrastructure and seller services. In addition, it offers SeaMoney digital financial services to individuals and businesses, including mobile wallet and payment services AirPay, ShopeePay, SPayLater, and other digital financial services brands; and payment processing services for Shopee. The company was formerly known as Garena Interactive Holding Limited and changed its name to Sea Limited in April 2017. Sea Limited was incorporated in 2009 and is headquartered in Singapore.
Latest APDN
- SEC Form DEFA14A filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Leadership Update
- SEC Form DEF 14A filed by Applied DNA Sciences Inc.
- SEC Form 424B5 filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form PRE 14A filed by Applied DNA Sciences Inc.
- SEC Form S-1 filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Latest SE
- NYSE Content Update: Global Medical Response to Go Public After $479 Million IPO
- Sea Limited Reports First Quarter 2026 Results
- Sea Limited to Report First Quarter 2026 Results
- SEC Form 4 filed by Chen Jingye
- SEC Form 4 filed by Ma David Y
- SEC Form 4 filed by Ye Gang
- SEC Form 4 filed by Wang Yanjun
- SEC Form 4 filed by Ma David Y
- SEC Form 4 filed by Ye Gang
- SEC Form 4 filed by Wang Yanjun